A groundbreaking cancer vaccine, OvarianVax, is currently being developed by researchers at the University of Oxford. This potential vaccine offers new hope in the fight against ovarian cancer, a disease known for its high mortality rate and silent progression. If successful, OvarianVax could prevent ovarian cancer from developing, changing the way the disease is approached… Read More »
September 11, 2023, the U.S. Food and Drug Administration announced1 it had approved reformulated monovalent COVID shots by Pfizer and Moderna for use in individuals 12 years of age and older. They also issued emergency use authorization (EUA) for use of the reformulated jabs in children aged 6 months to 11 years.2 The updated mRNA… Read More »
The Federal Reserve Bank of St. Louis runs FRED, a database of economic data that have been tracked since 1991.1 One of its categories is the U.S. population, aged 16 years and over, with a disability — a population that remained stable from 2016 to 2020, but jumped sharply in early 2021,2 coinciding with the… Read More »
This article was originally published here. COVID persists, but the COVID vaccine narrative has taken on so much water, the powers that be have stopped bailing, and are going to let these vaccines slowly sink. But what do they have in store for us next? There has been so much bad news about the vaccines… Read More »